Speciality European Pharma signs clinical research agreement with Central Manchester University Hospitals NHS Foundation Trust for the study of Bulkamid as a first line treatment for stress urinary incontinence
We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.
Back to jobs